Free Trial

Iterum Therapeutics (ITRM) SEC Filings & 10K Form

Iterum Therapeutics logo
$0.72 -0.02 (-3.09%)
Closing price 08/25/2025 03:58 PM Eastern
Extended Trading
$0.72 +0.00 (+0.42%)
As of 08/25/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Iterum Therapeutics SEC Filings

DateFilerForm TypeView
08/20/2025
7:15 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2025
6:00 AM
Dunne Michael W. (Reporting)
Iterum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
6:30 AM
Iterum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2025
6:15 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2025
4:00 PM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2025
7:00 AM
Iterum Therapeutics (Filer)
Form PRE 14A
07/03/2025
3:15 PM
Coyne Christine (Reporting)
Iterum Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2025
3:16 PM
Coyne Christine (Reporting)
Iterum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
6:15 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2025
6:15 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
6:30 AM
Iterum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2025
6:15 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
8:11 PM
Iterum Therapeutics (Filer)
Form 424B5
04/29/2025
8:16 PM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
7:00 AM
Iterum Therapeutics (Issuer)
Whalen Joseph John (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/10/2025
7:35 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
11:15 PM
Iterum Therapeutics (Filer)
Form EFFECT
02/14/2025
4:36 PM
ARMISTICE CAPITAL, LLC (Filed by)
Iterum Therapeutics (Subject)
Form SCHEDULE 13G/A
02/07/2025
3:33 PM
Iterum Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/07/2025
6:15 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
6:30 AM
Iterum Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/23/2025
5:30 PM
HUNT RONALD (Reporting)
Iterum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
5:30 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
6:04 AM
Iterum Therapeutics (Filer)
Form 424B5
11/21/2024
8:15 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:54 PM
Iterum Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/14/2024
6:30 AM
Iterum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2024
6:15 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:10 PM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
5:24 AM
Iterum Therapeutics (Filer)
Form 424B5
10/28/2024
5:06 AM
Iterum Therapeutics (Filer)
Form 424B5
10/25/2024
10:20 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
7:00 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
8:15 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
4:20 PM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
3:15 PM
Iterum Therapeutics (Filer)
Form DEFA14A
09/30/2024
6:30 AM
Iterum Therapeutics (Filer)
Form DEFA14A
09/24/2024
7:59 AM
Iterum Therapeutics (Filer)
Form DEFA14A
09/24/2024
8:01 AM
Iterum Therapeutics (Filer)
Form DEFA14A
09/23/2024
5:30 AM
Iterum Therapeutics (Filer)
Form DEFA14A
09/11/2024
3:50 PM
Iterum Therapeutics (Filer)
Form DEFA14A
Buffett’s $325 Billion Cash Problem — Solved by Gold? (Ad)

A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.tc pixel

Discover how you could front-run Buffett’s gold move with Garrett’s Top Four picks.
09/09/2024
5:15 AM
Iterum Therapeutics (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ITRM) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners